Order Article Reprints

Schrijver IT, Herderschee J, Théroude C, Kritikos A, Leijte G, Le Roy D, Brochut M, Chiche J-D, Perreau M, Pantaleo G, et al. Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients. Cells. 2024; 13(4):314. https://doi.org/10.3390/cells13040314

Schrijver, Irene T., Jacobus Herderschee, Charlotte Théroude, Antonios Kritikos, Guus Leijte, Didier Le Roy, Maelick Brochut, Jean-Daniel Chiche, Matthieu Perreau, Giuseppe Pantaleo, and et al. 2024. "Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients" Cells 13, no. 4: 314. https://doi.org/10.3390/cells13040314

Schrijver, I. T., Herderschee, J., Théroude, C., Kritikos, A., Leijte, G., Le Roy, D., Brochut, M., Chiche, J.-D., Perreau, M., Pantaleo, G., Guery, B., Kox, M., Pickkers, P., Calandra, T., & Roger, T. (2024). Myeloid-Derived Suppressor-like Cells as a Prognostic Marker in Critically Ill Patients: Insights from Experimental Endotoxemia and Intensive Care Patients. Cells, 13(4), 314. https://doi.org/10.3390/cells13040314